Table 1. Association between PPA2 expression and clinicopathologic characteristics in KIRC.
| Characteristic | n (%) | PPA2 expression (%) | p-value | |
|---|---|---|---|---|
| High | Low | |||
| Total | 150 (100) | 70 (46.7) | 80 (53.3) | |
| Age | 0.411 | |||
| <60 years | 87 (58.0) | 38 (54.3) | 49 (61.3) | |
| ≥ 60 years | 63 (42.0) | 32 (45.7) | 31 (38.8) | |
| Gender | 0.475 | |||
| Male | 107 (71.3) | 52 (74.3) | 55 (68.8) | |
| Female | 43 (28.7) | 18 (25.7) | 25 (31.2) | |
| Grade | 0.014 | |||
| G1/2 | 103 (68.7) | 41 (58.6) | 62 (77.5) | |
| G3/4 | 47 (31.3) | 29 (41.4) | 18 (22.5) | |
| N stage | 0.248 | |||
| N0 | 147 (98.0) | 70 (100) | 77 (96.2) | |
| N1 | 3 (2.0) | 0 (0) | 3 ( 3.8) | |
| AJCC stage | 0.141 | |||
| I/II | 138 (92.0) | 67 (95.7) | 71 (88.8) | |
| III/IV | 12 (8.0) | 3 ( 4.3) | 9 (11.2) | |
Notes.
Abbreviations
- KIRC
- kidney renal clear cell carcinoma
- AJCC
- American Joint Committee on Cancer